These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 21199775)

  • 1. Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening.
    Gorini G; Bell RL; Mayfield RD
    Prog Mol Biol Transl Sci; 2011; 98():293-347. PubMed ID: 21199775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational approach to develop novel medications on alcohol addiction: focus on neuropeptides.
    Ubaldi M; Bifone A; Ciccocioppo R
    Curr Opin Neurobiol; 2013 Aug; 23(4):684-91. PubMed ID: 23648086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A translational approach to novel medication development for protracted abstinence.
    Mason BJ; Higley AE
    Curr Top Behav Neurosci; 2013; 13():647-70. PubMed ID: 22351425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of alcohol dependence: past, present and future research.
    Leggio L; Addolorato G
    Curr Pharm Des; 2010; 16(19):2074-5. PubMed ID: 20482504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate genes, pathways and mechanisms for alcoholism: an expanded convergent functional genomics approach.
    Rodd ZA; Bertsch BA; Strother WN; Le-Niculescu H; Balaraman Y; Hayden E; Jerome RE; Lumeng L; Nurnberger JI; Edenberg HJ; McBride WJ; Niculescu AB
    Pharmacogenomics J; 2007 Aug; 7(4):222-56. PubMed ID: 17033615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic approaches and identification of novel therapeutic targets for alcoholism.
    Gorini G; Harris RA; Mayfield RD
    Neuropsychopharmacology; 2014 Jan; 39(1):104-30. PubMed ID: 23900301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.
    Bell RL; Hauser S; Rodd ZA; Liang T; Sari Y; McClintick J; Rahman S; Engleman EA
    Int Rev Neurobiol; 2016; 126():179-261. PubMed ID: 27055615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapies for alcoholism: the old and the new.
    Olive MF
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):2-4. PubMed ID: 20232494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New horizons for therapeutics in drug and alcohol abuse.
    Jupp B; Lawrence AJ
    Pharmacol Ther; 2010 Jan; 125(1):138-68. PubMed ID: 19917308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational drugs for alcohol use disorders: a review of preclinical data.
    Ch'Ng SS; Lawrence AJ
    Expert Opin Investig Drugs; 2018 May; 27(5):459-474. PubMed ID: 29723484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic receptor system as a target for treating alcohol abuse and dependence.
    Rahman S; Prendergast MA
    Recent Pat CNS Drug Discov; 2012 Aug; 7(2):145-50. PubMed ID: 22574675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel medication targets for the treatment of alcoholism: preclinical studies.
    Rezvani AH; Lawrence AJ; Arolfo MP; Levin ED; Overstreet DH
    Recent Pat CNS Drug Discov; 2012 Aug; 7(2):151-62. PubMed ID: 22574676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing Pharmacotherapy Development from Preclinical Animal Studies.
    Egli M
    Handb Exp Pharmacol; 2018; 248():537-578. PubMed ID: 29374834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turning the clock ahead: potential preclinical and clinical neuropharmacological targets for alcohol dependence.
    Leggio L; Cardone S; Ferrulli A; Kenna GA; Diana M; Swift RM; Addolorato G
    Curr Pharm Des; 2010; 16(19):2159-18. PubMed ID: 20482506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical Evidence of Preclinical and Clinical Reports on Target-Based Therapy in Alcohol Used Disorder.
    Prajapati SK; Bhaseen S; Krishnamurthy S; Sahu AN
    Neurochem Res; 2020 Feb; 45(2):491-507. PubMed ID: 31898084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational studies of alcoholism: bridging the gap.
    Zahr NM; Sullivan EV
    Alcohol Res Health; 2008; 31(3):215-30. PubMed ID: 20041042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical and clinical pharmacology of alcohol dependence.
    Tambour S; Quertemont E
    Fundam Clin Pharmacol; 2007 Feb; 21(1):9-28. PubMed ID: 17227441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders.
    Freeman WM; Vrana KE
    Alcohol Clin Exp Res; 2010 Jun; 34(6):946-54. PubMed ID: 20374220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics.
    Johnson BA; Swift RM; Ait-Daoud N; DiClemente CC; Javors MA; Malcolm RJ
    Alcohol Clin Exp Res; 2004 Feb; 28(2):295-301. PubMed ID: 15112937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological approaches to the management of alcohol addiction.
    Addolorato G; Armuzzi A; Gasbarrini G; De Lorenzi G; Ancona C; Abenavoli L; Parente A; Leggio L; Capristo E; Greco AV; Janiri L; Pozzi G; Taranto C; Caputo F; Bernardi M; Stefanini GF; Foschi FG;
    Eur Rev Med Pharmacol Sci; 2002; 6(5):89-97. PubMed ID: 12776801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.